Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20346637rdf:typepubmed:Citationlld:pubmed
pubmed-article:20346637lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0016860lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C2709270lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0001758lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0444956lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0036082lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0036085lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C1708715lld:lifeskim
pubmed-article:20346637lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:20346637pubmed:issue5lld:pubmed
pubmed-article:20346637pubmed:dateCreated2011-4-18lld:pubmed
pubmed-article:20346637pubmed:abstractTextNeurohormonal activation and inflammation characterizes heart failure, relates to outcome, and is a therapeutic target. The aim of this study was to evaluate the effects of high-dose furosemide plus small-volume hypertonic saline solutions (HSS) on natriuretic peptides and immuno-inflammatory marker levels and to analyze, after treatment, the response to acute saline loading.lld:pubmed
pubmed-article:20346637pubmed:languageenglld:pubmed
pubmed-article:20346637pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:citationSubsetIMlld:pubmed
pubmed-article:20346637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20346637pubmed:statusMEDLINElld:pubmed
pubmed-article:20346637pubmed:monthMaylld:pubmed
pubmed-article:20346637pubmed:issn1590-3729lld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:LicataGGlld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:PintoAAlld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:CarusoCClld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:ScaglioneRRlld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:TuttolomondoA...lld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:CorraoSSlld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:Di RaimondoDDlld:pubmed
pubmed-article:20346637pubmed:authorpubmed-author:Di SciaccaRRlld:pubmed
pubmed-article:20346637pubmed:copyrightInfoCopyright © 2009 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:20346637pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20346637pubmed:volume21lld:pubmed
pubmed-article:20346637pubmed:ownerNLMlld:pubmed
pubmed-article:20346637pubmed:authorsCompleteYlld:pubmed
pubmed-article:20346637pubmed:pagination372-9lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:meshHeadingpubmed-meshheading:20346637...lld:pubmed
pubmed-article:20346637pubmed:year2011lld:pubmed
pubmed-article:20346637pubmed:articleTitleChanges in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.lld:pubmed
pubmed-article:20346637pubmed:affiliationDipartimento Biomedico di Medicina Interna e Specialistica, Università degli Studi di Palermo, p.zza delle Cliniche n.2, 90127 Palermo, Italy. brunotutto@unipa.itlld:pubmed
pubmed-article:20346637pubmed:publicationTypeJournal Articlelld:pubmed